Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation

Behaviour Research and Therapy

Volumn 48, Issue 8, 2010, Pages 720-727

  Otto, Michael W ^a   McHugh, R Kathryn ^a   Simon, Naomi M ^b   Farach, Frank J ^b   Worthington, John J ^b   Pollack, Mark H ^b  

^a BOSTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benzodiazepines; Cognitive behavior therapy; Drug withdrawal.; Panic disorder

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CLONAZEPAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DOSE REDUCTION; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; PANIC; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RELAXATION TRAINING; THERAPY EFFECT;

ADULT; ALPRAZOLAM; BENZODIAZEPINES; CLONAZEPAM; COGNITIVE THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; FEMALE; HUMANS; MALE; PANIC DISORDER; RECURRENCE; RELAXATION THERAPY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77955278060     PISSN: 00057967     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brat.2010.04.002     Document Type: Article

References (51)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Author, Washington, DC. 4th ed.
2. Barlow D.H., Craske M.G. Mastery of your anxiety and panic (MAP) 1989, Graywind, Albany, NY.
3. Barlow D.H., Craske M.G., Cerny J.A., Klosko J.S. Behavioral treatment of panic disorder. Behavior Therapy 1989, 20:261-282.
4. Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine or their combination for panic disorder: a randomized controlled trial. Journal of the American Medical Association 2000, 283:2529-2536.
5. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 1988, 56:893-897.
6. Beck A.T., Steer R.A. Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology 1984, 40:1365-1367.
7. Bernstein D.A., Borkovec T.D. Progressive relaxation training 1973, Research Press, Champaign, IL.
8. Borkovec T.D., Mathews A.M. Treatment of nonphobic anxiety disorders: a comparison of nondirective, cognitive, and coping desensitization therapy. Journal of Clinical and Consulting Psychology 1988, 56:877-884.
9. Bruce T.J., Spiegel D.A., Hegel M.T. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies. American Journal of Psychiatry 1999, 67:151-156.
10. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd ed.
11. Colvin M. A counseling approach to outpatient benzodiazepine detoxification. Journal of Psychoactive Drugs 1983, 15:105-108.
12. Craske M.G., Brown T.A., Barlow D.H. Behavioral treatment of panic: a two year follow-up. Behavior Therapy 1991, 22:289-304.
13. DiNardo P.A., Brown T.A., Barlow D.H. Anxiety Disorders Interview Schedule for DSM-IV: Lifetime version (ADIS-IV-L) 1994, Psychological Corporation, San Antonia, TX.
14. Dupont R.L. Thinking about stopping treatment for panic disorder. Journal of Clinical Psychiatry 1990, 51:38-45.
15. Fontaine R., Chouinard G., Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 1984, 141:848-852.
16. Fyer A.J., Liebowitz M.R., Gorman J.M., Campeas R., Levin A., Davies S.O., et al. Discontinuation of alprazolam treatment in panic patients. American Journal of Psychiatry 1987, 144:303-308.
17. Glass G.V., McGaw B., Smith M.L. Meta-analysis in social research 1981, Sage, Beverly Hills, CA.
18. Gosselin P., Ladouceur R., Morin C.M., Dugas M.J., Baillargeon L. Benzodiazepine discontinuation among adults with GAD: a randomized trial of cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology 2006, 74:908-919.
19. Gould R.A., Buckminster D., Pollack M.H., Otto M.W., Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clinical Psychology: Science and Practice 1997, 4:291-306.
20. Gould R.A., Otto M.W., Pollack M.H. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review 1995, 15:819-844.
21. Gould R.A., Otto M.W., Pollack M.H., Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: a preliminary meta-analysis. Behavior Therapy 1997, 28:285-305.
22. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
23. Hegel M.T., Ravaris C.L., Ahles T.A. Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy 1994, 25:183-195.
24. Lader M.H., Ron M., Petursson H. Computed axial brain tomography in long-term benzodiazepine users. Psychological Medicine 1984, 14:203-206.
25. McHugh R.K., Otto M.W., Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cost-efficacy of individual and combined treatments for panic disorder. Journal of Clinical Psychiatry 2007, 68:1038-1044.
26. Mellman T.A., Uhde T.W. Withdrawal syndrome with gradual tapering of alprazolam. American Journal of Psychiatry 1986, 143:1464-1466.
27. Michelini S., Cassano G.B., Frare F., Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry 1996, 29:127-134.
28. Morin C.M., Bastien C., Guay B., Radouco-Thomas M., Leblanc J., Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. American Journal of Psychiatry 2004, 161:332-342.
29. Noyes R., Garvey M.J., Cook B., Suelzer M. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry 1991, 148:517-523.
30. Otto M.W., Hong J.J., Safren S.A. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy. Current Pharmaceutical Design 2002, 8:75-80.
31. Otto M.W., Pollack M.H. Stopping anxiety medication (Therapist guide) 2009, Oxford University Press, New York. 2nd ed.
32. Otto M.W., Pollack M.H., Maki K.M. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology 2000, 68:556-563.
33. Otto M.W., Pollack M.D., Meltzer-Brody S., Rosenbaum J.F. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patient. Psychopharmacology Bulletin 1992, 28:123-130.
34. Otto M.W., Pollack M.H., Sachs G.S., Reiter S.R., Meltzer-Brody S., Rosenbaum J.F. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry 1993, 150:1485-1490.
35. Otto M.W., Safren S.A., Pollack M.H. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. Journal of Anxiety Disorders 2004, 18:69-87.
36. Oude Voshaar R.C., Couvée J.E., van Balkom A.J., Mulder P.G., Zitman F.G. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. British Journal of Psychiatry 2006, 189:213-220.
37. Oude-Voshaar R.C., Gorgels W.J., Mol A.J., van Balkom A.J., Van de Lisdonk E.H., et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-conditioned, randomized controlled trial. British Journal of Psychiatry 2006, 182:498-504.
38. Parr J.M., Kavanagh D.J., Cahill L., Mitchell G., Young R.Mc.D. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009, 104:13-24.
39. Pecknold J.C., Swinson R.P., Kuck K., Lewis C.P. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, III: discontinuation effects. Archives of General Psychiatry 1988, 45:429-436.
40. Peterson R.A., Reiss S. Anxiety sensitivity index revised manual 1992, International Diagnostic Systems Publishing Corportation, Worthington, OH.
41. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behaviour Research and Therapy 1986, 24:1-8.
42. Rickels K., Schweizer E., Case W.G., Greenblatt D.J. Long-term therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation. Archives of General Psychiatry 1990, 47:899-907.
43. Roy-Byrne P.P., Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. American Journal of Medicine 1988, 84:1041-1052.
44. Salkovskis P.M., Clark D.M., Hackmann A., Wells A., Gelder M.G. An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia. Behaviour Research and Therapy 1999, 37:559-574.
45. Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Journal of Psychiatric Research 1993, 27:97-110.
46. Schmidt N.B., Woolaway-Bickel K., Trakowski J., Santiago H., Storey J., Koselka M., et al. Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retaining. Journal of Consulting and Clinical Psychology 2000, 68:417-424.
47. Schweizer E., Rickels K., Case W.G., Greenblatt D.J. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Archives of General Psychiatry 1991, 48:448-452.
48. Spiegel D.A., Bruce T.J., Gregg S.F., Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?. American Journal of Psychiatry 1994, 151:876-881.
49. Stewart S.H., Westra H.A., Thompson C.E., Conrad B.E. Effects of naturalistic benzodiazepine use on the selective processing of threat cues among anxiety disorder patients. Cognitive Therapy and Research 2000, 24:67-85.
50. Tyrer P., Murphy S., Riley P. The benzodiazepine withdrawal symptom questionnaire. Journal of Affective Disorders 1990, 19:53-61.
51. Whittal M.L., Otto M.W., Hong J.J. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series. Behaviour Research and Therapy 2001, 39:939-945.